Quantcast
Study Calls Into Question Link Between Prenatal

Study Calls Into Question Link Between Prenatal Antidepressant Exposure And Autism Risk

Noah Brown, Massachusetts General Hospital Previously reported autism risk appears to be attributable to mother's illness, not medication Previous studies that have suggested an increased risk of autism among children of women who took...

Latest ADHD Stories

2014-08-28 12:30:15

In the news release, New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications, issued 28-Aug-2014 by Coalition to Prevent ADHD Medication Misuse over PR Newswire, the contact information should read "Kelly Walker, 717-231-5338" rather than "Kelly Walker, 717-231-5538" as incorrectly transmitted by PR Newswire. The complete, corrected release follows: New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications Coalition to Focus Efforts on...

2014-08-28 08:27:28

Coalition to Focus Efforts on College Students WAYNE, Pa., Aug. 28, 2014 /PRNewswire/ -- Today is the official launch of a newly formed Coalition of medical, mental health, higher education, student and pharmaceutical organizations that will work together to help prevent misuse, abuse and diversion of ADHD prescription stimulant medication. The Coalition will initially focus its efforts on college students. Although reported rates of nonmedical use vary, a 2013 study at one large...

child eyes adhd
2014-08-15 09:31:22

American Friends of Tel Aviv University TAU researchers develop diagnostic tool for the most commonly misdiagnosed disorder Attention Deficit Hyperactivity Disorder (ADHD) is the most commonly diagnosed — and misdiagnosed — behavioral disorder in children in America, according to the Centers for Disease Control and Prevention. Unfortunately, there are currently no reliable physiological markers to diagnose ADHD. Doctors generally diagnose the disorder by recording a medical and...

2014-07-31 23:19:00

Parent company C8 Sciences’ innovative ACTIVATE™ program at the center of helping ADHD in the classroom while delivering real-time cognitive data reports and greatly improving academic outcomes. New Haven, Connecticut (PRWEB) July 31, 2014 Connecticut-based C8 Sciences, developers and marketers of neuroscience-based cognitive assessment and development products including the game-changing ACTIVATE™ program, has announced a no-cost webinar through its C8 Schools to help teachers...

2014-07-24 23:14:37

Attention Point® is pleased to announce the “Weiss ADHD Comorbid Screen” (WACS) and the “Teacher Report of School Function”, both developed by Dr. Margaret Weiss, are now available as a part of DefiniPoint®, the nation’s first complete suite of online ADHD assessment tools. Roanoke, VA (PRWEB) July 24, 2014 “I developed the ADHD Comorbid Screen because, I wanted to help clinicians gather comorbid symptom information which would allow them to focus the clinical...

2014-07-23 23:31:41

Two recent studies reveal that child abuse is much more common in ADHD and dyslexia. In Dr. Harold Levinson’s clinical experience, early and effective medical treatment rapidly “normalizes” overall functioning and so may minimize or prevent child abuse and many other impairments from arising. Great Neck, N.Y. (PRWEB) July 22, 2014 Two recent studies indicate that previously untreated adults with dyslexia and ADHD were significantly more abused as children than those without these...

2014-07-17 16:25:39

LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies of Vyvanse(R) (lisdexamfetamine dimesylate) compared with Concerta (methylphenidate HCl) with a placebo reference arm in adolescents aged 13-17 diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). In SPD489-406, the forced-dose titration study, Vyvanse was found to be statistically superior to...

2014-07-10 10:28:40

Boston Children's Hospital Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS ONE. The study highlights...

2014-07-09 16:28:10

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS...

2014-07-09 08:27:34

LOS ANGELES, July 9, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles (UCLA) focused on the treatment of...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related